Patent Expiry

Patent/Exclusivity Expiry: XACIATO

September 22, 2036

Company: Dare Bioscience, Inc. (DARE)
Drug: XACIATO

Other upcoming events for DARE

Phase 1 StartPhase 1 Start: An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: XACIATO — DARE Patent Expiry | BioSniper